Core Viewpoint - The company has approved the use of raised funds to replace pre-invested self-raised funds for project investments and paid issuance expenses, ensuring compliance with regulatory requirements [1][7][8] Fundraising Overview - The company issued 10,206,185 shares at a price of RMB 29.10 per share, raising a total of RMB 296,999,983.50, with a net amount after expenses [1] - A special verification report was issued by Zhongxinghua Accounting Firm, and independent financial advisor Zhongtai Securities provided a non-objection opinion on the matter [1][8] Fund Management and Usage - The company has established a dedicated account storage system for managing raised funds, with a tripartite supervision agreement signed with Industrial and Commercial Bank of China and Zhongtai Securities [2] - The total amount allocated for cash consideration and intermediary fees is RMB 29,700,000, which accounts for 100% of the raised funds [4] Pre-Investment of Self-Raised Funds - As of May 30, 2025, the actual investment amount from self-raised funds is RMB 108,116,982.40, which includes RMB 99,913,208.80 for cash consideration and RMB 8,203,773.60 for intermediary fees [6] - The company plans to use the raised funds to replace the pre-invested self-raised funds totaling RMB 108,116,982.40 [6] Approval Process and Opinions - The board of directors and the supervisory board approved the proposal on June 6, 2025, without the need for shareholder meeting approval [6][7] - The supervisory board confirmed that the process followed necessary approval procedures and complied with relevant regulations [7] - The independent financial advisor affirmed that the proposed use of raised funds aligns with legal requirements and does not harm the interests of the company and its shareholders [8]

Meeting Overview - The fourth supervisory board meeting of Huada Automotive Technology Co., Ltd. was held on June 6, 2025, in Jiangsu Province, with all three supervisors present, confirming the legality and validity of the meeting [1]. Resolutions Passed - The supervisory board approved the proposal to use raised funds to replace pre-invested project funds and paid issuance expenses, with unanimous support from all supervisors [2]. - The board also approved the use of part of the idle raised funds for cash management, emphasizing that this action complies with relevant regulations and does not harm the interests of the company or its shareholders [2][3].

Core Viewpoint - The company, Aibo Medical, has approved the use of raised funds to replace self-raised funds that were previously invested in projects and paid issuance expenses, totaling RMB 40,556,134.86 [1][2] Fundraising Overview - Aibo Medical issued 3,593,615 shares at a price of RMB 79.20 per share, raising a total of RMB 284,614,308.00 in 2024 [1] - The net amount raised after deducting related issuance expenses is less than the intended investment amount, allowing the company to use self-raised funds for initial investments [1] Investment Project Details - The total investment amount for the projects is RMB 422,430,700, with RMB 284,614,308 intended to be funded by the raised funds [1] - The company has pre-invested self-raised funds in the projects, with specific amounts detailed for each project [1] Approval Process - The board of directors and the supervisory board approved the proposal on May 29, 2025, confirming compliance with regulations regarding the replacement of funds within six months of the funds being received [1][2] Opinions from Supervisory Board and Auditors - The supervisory board agrees that the replacement of self-raised funds aligns with the company's interests and complies with relevant laws and regulations [2] - The auditing firm, Xinyong Zhonghe, confirmed that the management's report accurately reflects the situation regarding the use of self-raised funds [2]

Group 1 - The report is a special audit report regarding the replacement of pre-invested funds for projects and payment of issuance costs by Heilongjiang Tianyouwei Electronics Co., Ltd [1][2] - The company has raised a total of RMB 3,740,000,000 through the issuance of 40 million new shares at a price of RMB 93.50 per share, with a net amount of RMB 3,526,941,817.64 after deducting issuance costs [2][3] - The company has established a special account for the management of raised funds and signed a tripartite supervision agreement with the bank and sponsor [3] Group 2 - The company committed to invest the net proceeds from the IPO into specific projects as outlined in the prospectus, with a total investment amount of RMB 306,521.32 million and an intended use of raised funds amounting to RMB 300,436.57 million [3]

Core Viewpoint - The company, Heilongjiang Tianyouwei Electronics Co., Ltd., is utilizing raised funds to replace pre-invested self-raised funds for its projects and to cover issuance costs, following regulatory compliance and internal approvals [2][5][7]. Fundraising Overview - The company has been approved to publicly issue 40 million shares at a price of 93.50 RMB per share, raising a total of 3.74 billion RMB, with a net amount of approximately 3.53 billion RMB after deducting issuance costs of about 213.06 million RMB [2][3]. - The total amount of over-raised funds is approximately 522.58 million RMB, and all raised funds have been deposited [2][3]. Fund Utilization - The raised funds will be allocated to several projects, including: - Automotive Electronics Intelligent Factory Construction - Intelligent Cockpit Production Base Construction - Harbin Global Automotive Electronics R&D Center Construction - Korean Automotive Electronics Factory Construction - The total planned investment for these projects is approximately 3.68 billion RMB, with adjustments leading to a new total of about 3.53 billion RMB [3][4]. Pre-Investment of Self-Raised Funds - As of May 9, 2025, the company has pre-invested approximately 285.05 million RMB of self-raised funds into the projects, which it plans to replace with the raised funds [4][6]. - The company has also pre-paid issuance costs totaling approximately 21.31 million RMB, with about 891.51 thousand RMB to be replaced by the raised funds [4][6]. Approval Process - The board of directors and the supervisory board approved the use of raised funds to replace pre-invested self-raised funds and issuance costs on May 28, 2025, confirming compliance with relevant regulations [5][6][7]. - The approval process adhered to the requirements set forth by the Shanghai Stock Exchange and other regulatory guidelines, ensuring no conflict with the implementation of the fundraising projects [6][7].

Group 1 - The company announced the use of raised funds to replace self-raised funds of 285 million yuan for investment projects and 8.9151 million yuan for issuance expenses, totaling 294 million yuan [1] - The replacement of raised funds occurred within six months of the funds being received, complying with relevant laws and regulations [1]

中信建投证券股份有限公司 关于袁隆平农业高科技股份有限公司 使用募集资金置换已支付发行费用的自筹资金的 中信建投证券股份有限公司（以下简称"中信建投证券" "保荐人"）作为袁 隆平农业高科技股份有限公司（以下简称"隆平高科" "公司"）向特定对象发行 股票的保荐人，根据《证券发行上市保荐业务管理办法》《上市公司监管指引第 自律监管指引第 1 号——主板上市公司规范运作》等相关法律法规的要求，对隆 平高科使用募集资金置换已支付发行费用的自筹资金的事项进行了审慎核查，具 体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意袁隆平农业高科技股份有限公 司向特定对象发行股票注册的批复》（证监许可〔2025〕700 号）核准，公司本 次向特定对象发行股票数量 152,477,763 股，发行价格 7.87 元/股，募集资金总额 为人民币 1,199,999,994.81 元，扣除发行费用（不含税）人民币 12,473,584.90 元， 募集资金净额为人民币 1,187,526,409.91 元，募集资金已于 2025 年 4 月 18 日划 至公司指定账户。天健会计师事务所（特殊普通合伙）对公 ...

证券代码：000998 证券简称：隆平高科 公告编号：2025-35 袁隆平农业高科技股份有限公司 关于使用募集资金置换已支付发行费用的自筹资金 的公告 二、募集资金投资项目情况 根据《袁隆平农业高科技股份有限公司向特定对象发行股票募集说明书（修订 稿）》，本次发行的募集资金，扣除发行费用后的募集资金净额将全部用于偿还银行贷 款及补充流动资金，有助于公司优化资产负债结构、改善财务状况，增强公司高质量 研发投入、运营发展及产业整合的资金实力，进一步提升公司种业龙头地位。 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意袁隆平农业高科技股份有限公 司向特定对象发行股票注册的批复》 （证监许可〔2025〕700 号），公司已完成向特定 对象发行股份 152,477,763 股，发行价格人民币 7.87 元/股。本次发行共计募集资金 汇入公司指定资金专户。另减除保荐承销费、律师费、审计及验资费等与发行权益性 证 券 直 接 相 关 的 新 增 外 部 费 用 5,273,584.90 元 后 ， 公 司 本 次 募 集 资 金 净 额 为 验证，并于 2025 年 4 月 21 日出具《验资报告》（天 ...

证券代码：605300 证券简称：佳禾食品 公告编号：2025-047 禾食品"）收到中国证券监督管理委员会出具的《关于同意佳禾食品工业股份有 限公司向特定对象发行股票注册的批复》 （证监许可202570 号），同意公司向特 定对象发行股票的注册申请。公司已向特定对象发行普通股（A 股）54,388,597 股，每股发行价格人民币 13.33 元，募集资金总额人民币 724,999,998.01 元。本 次募集资金各项发行费用合计（不含增值税）人民币 13,909,476.44 元，扣除不 含税的发行费用后，实际募集资金净额为人民币 711,090,521.57 元。 上述资金到位情况已经天衡会计师事务所（特殊普通合伙）审验，并于 2025 年 3 月 7 日出具"天衡验字（2025）00009 号"《验资报告》。公司已将上述募 集资金存放于募集资金专项账户，并与保荐机构、存放募集资金的相关银行签署 了募集资金监管协议，对募集资金的存放和使用进行专户管理。 二、募集资金投资项目拟投入募集资金金额的调整情况 根据公司在《佳禾食品工业股份有限公司 2023 年度向特定对象发行 A 股股 票募集说明书》中披露的募集 ...

证券代码：605300 证券简称：佳禾食品 公告编号：2025-045 佳禾食品工业股份有限公司 第三届监事会第四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 佳禾食品工业股份有限公司（以下简称"公司"）第三届监事会第四次会议 于 2025 年 5 月 23 日在公司会议室以现场结合通讯方式召开，会议通知已于 2025 年 5 月 16 日通过邮件的方式送达各位监事。会议应参加表决的监事 3 人，实际 参加表决的监事 3 人。 会议由监事会主席周月军主持。会议的召开符合《公司法》《公司章程》等 有关规定，会议审议了如下议案并形成决议： 一、审议通过《关于取消公司监事会并修订 <公司章程> 及其附件的议案》 （公 告编号：2025-046）。 表决情况：同意 3 票，反对 0 票，弃权 0 票。 本议案尚需提交股东会审议。 二、审议通过《关于使用募集资金置换预先投入募投项目及已支付发行费 用的自筹资金的议案》 监事会认为：公司本次使用募集资金置换预先投入募投项目及已支付发行费 用的自筹资金事项，其置换时间距募集资金 ...